CoChat

New concept of cytotoxic immunoconjugate therapy targeting cancer‐induced fibrin clots

Open access
Yasunaga, Masahiro, Manabe, Shino, Matsumura, Yasuhiro · 2011 · Cancer Science
Cited by 76

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Fibrin clots in non‐malignant conditions form only at the onset or during the active stage of disease and disappear within a few weeks as a result of plasmin digestion or replacement with collagen. In contrast, fibrin clot formation and subsequent replacement with collagen in cancer persist for as long as the cancer cells survive in the body. We developed an anti‐fibrin chimeric antibody that reacts with fibrin only, and not fibrinogen (the precursor of fibrin), and then attached an anticancer agent (ACA) to the antibody. Thus, the immunoconjugate did not create an immune complex in the blood stream and was selectively accumulated to fibrin clots in the tumor stroma to create a scaffold, from which effective sustained release of the ACA occurred. In a mouse model, the ACA diffused throughout the tumor tissue to damage both tumor cells and vessels, resulting in potent antitumor activity in stroma‐rich spontaneous tumors. This new cancer stroma‐targeting therapy may result in an increased duration of drug exposure and be a highly effective new therapy, particularly for refractory, stroma‐rich cancers. (Cancer Sci 2011; 102: 1396–1402)

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1349-7006.2011.01954.x

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 76

Metadata

Authors
Yasunaga, M., Manabe, S., & Matsumura, Y.
Venue
Cancer Science
Publisher
Wiley
Published
2011-05-09
Volume
102
Issue
7
Pages
1396-1402
ISSN
  • 1347-9032 (ISSN-L)
  • 1349-7006
OpenAlex
W1975580277
Cited by
76
References
4
FWCI
3.68
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: New concept of cytotoxic immunoconjugate therapy targeting cancer‐induced fibrin clots. https://app.cochat.ai/papers/10.1111/j.1349-7006.2011.01954.x
The paper
Yasunaga, M., Manabe, S., & Matsumura, Y. (2011). New concept of cytotoxic immunoconjugate therapy targeting cancer‐induced fibrin clots. Cancer Science. https://doi.org/10.1111/j.1349-7006.2011.01954.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.